ADESSO SE (ADN1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ADN1 - DE000A0Z23Q5 - Common Stock
91 EUR
+1.6 (+1.79%)
Overall ADN1 gets a fundamental rating of 5 out of 10. We evaluated ADN1 against 73 industry peers in the IT Services industry. Both the profitability and the financial health of ADN1 get a neutral evaluation. Nothing too spectacular is happening here. ADN1 is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
ADN1 had positive earnings in the past year.
In the past year ADN1 had a positive cash flow from operations.
Each year in the past 5 years ADN1 has been profitable.
Each year in the past 5 years ADN1 had a positive operating cash flow.
1.2 Ratios
ADN1's Return On Assets of 2.45% is on the low side compared to the rest of the industry. ADN1 is outperformed by 60.27% of its industry peers.
With a Return On Equity value of 10.90%, ADN1 perfoms like the industry average, outperforming 50.68% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.23%, ADN1 is doing worse than 64.38% of the companies in the same industry.
ADN1 had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 26.63%.
The last Return On Invested Capital (5.23%) for ADN1 is above the 3 year average (3.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROIC | 5.23% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
1.3 Margins
Looking at the Profit Margin, with a value of 0.99%, ADN1 is doing worse than 64.38% of the companies in the same industry.
ADN1's Profit Margin has declined in the last couple of years.
ADN1 has a worse Operating Margin (2.96%) than 68.49% of its industry peers.
ADN1's Operating Margin has declined in the last couple of years.
ADN1 has a better Gross Margin (85.30%) than 75.34% of its industry peers.
ADN1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% |
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN1 is destroying value.
Compared to 1 year ago, ADN1 has less shares outstanding
ADN1 has more shares outstanding than it did 5 years ago.
ADN1 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.63 indicates that ADN1 is not in any danger for bankruptcy at the moment.
ADN1 has a Altman-Z score of 3.63. This is in the better half of the industry: ADN1 outperforms 78.08% of its industry peers.
The Debt to FCF ratio of ADN1 is 7.88, which is on the high side as it means it would take ADN1, 7.88 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.88, ADN1 is not doing good in the industry: 67.12% of the companies in the same industry are doing better.
ADN1 has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.60, ADN1 is doing worse than 75.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Altman-Z | 3.63 |
ROIC/WACC0.94
WACC5.57%
2.3 Liquidity
ADN1 has a Current Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
ADN1's Current ratio of 1.30 is in line compared to the rest of the industry. ADN1 outperforms 57.53% of its industry peers.
A Quick Ratio of 1.30 indicates that ADN1 should not have too much problems paying its short term obligations.
ADN1's Quick ratio of 1.30 is fine compared to the rest of the industry. ADN1 outperforms 65.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ADN1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.98%, which is quite impressive.
ADN1 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.02% yearly.
ADN1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.60%.
The Revenue has been growing by 23.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
3.2 Future
ADN1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.75% yearly.
Based on estimates for the next years, ADN1 will show a quite strong growth in Revenue. The Revenue will grow by 10.61% on average per year.
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.75%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
ADN1 is valuated quite expensively with a Price/Earnings ratio of 28.53.
The rest of the industry has a similar Price/Earnings ratio as ADN1.
ADN1's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.00.
The Price/Forward Earnings ratio is 16.09, which indicates a correct valuation of ADN1.
ADN1's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.70, ADN1 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.53 | ||
| Fwd PE | 16.09 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADN1 indicates a somewhat cheap valuation: ADN1 is cheaper than 68.49% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ADN1 is valued a bit cheaper than 61.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.71 | ||
| EV/EBITDA | 6.64 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ADN1's earnings are expected to grow with 63.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y76.08%
EPS Next 3Y63.28%
5. Dividend
5.1 Amount
With a yearly dividend of 0.85%, ADN1 is not a good candidate for dividend investing.
ADN1's Dividend Yield is comparable with the industry average which is at 2.29.
With a Dividend Yield of 0.85, ADN1 pays less dividend than the S&P500 average, which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
5.2 History
On average, the dividend of ADN1 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years5
Div Non Decr Years6
5.3 Sustainability
31.75% of the earnings are spent on dividend by ADN1. This is a low number and sustainable payout ratio.
The dividend of ADN1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.75%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
FRA:ADN1 (1/9/2026, 4:41:07 PM)
91
+1.6 (+1.79%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners20.34%
Inst Owner ChangeN/A
Ins Owners50.28%
Ins Owner ChangeN/A
Market Cap594.23M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts81.54
Price Target126.63 (39.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.53 | ||
| Fwd PE | 16.09 | ||
| P/S | 0.28 | ||
| P/FCF | 12.71 | ||
| P/OCF | 7.65 | ||
| P/B | 3.11 | ||
| P/tB | 11.73 | ||
| EV/EBITDA | 6.64 |
EPS(TTM)3.19
EY3.51%
EPS(NY)5.65
Fwd EY6.21%
FCF(TTM)7.16
FCFY7.87%
OCF(TTM)11.9
OCFY13.07%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.34
PEG (5Y)N/A
Graham Number45.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROCE | 11.91% | ||
| ROIC | 5.23% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 8.22% | ||
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% | ||
| FCFM | 2.22% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Debt/EBITDA | 2.26 | ||
| Cap/Depr | 42.37% | ||
| Cap/Sales | 1.47% | ||
| Interest Coverage | 5.03 | ||
| Cash Conversion | 57.42% | ||
| Profit Quality | 224.33% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 3.63 |
F-Score7
WACC5.57%
ROIC/WACC0.94
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.75%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.61%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year304.77%
EBIT Next 3Y78.82%
EBIT Next 5Y44.55%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%
ADESSO SE / ADN1.DE FAQ
What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.
Can you provide the valuation status for ADESSO SE?
ChartMill assigns a valuation rating of 5 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.
What is the profitability of ADN1 stock?
ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ADESSO SE (ADN1.DE) stock?
The Price/Earnings (PE) ratio for ADESSO SE (ADN1.DE) is 28.53 and the Price/Book (PB) ratio is 3.11.
Can you provide the expected EPS growth for ADN1 stock?
The Earnings per Share (EPS) of ADESSO SE (ADN1.DE) is expected to grow by 83.56% in the next year.